The document summarizes venture capital trends from 1970 to 2013. It finds that while the number of active venture capital firms decreased after 2000, the amount of capital managed increased. Venture capital fundraising was down in 2013 but still substantial at $16.7 billion. Software continues to attract the most investment, receiving over 25% of total venture capital dollars. Biotech and medical devices also receive significant funding amounts. The San Diego region saw over $1 billion in venture capital funding in 2013, led by biotech deals. More life science companies went public in 2013 than the previous 5 years combined. The author concludes that venture capital continues fueling innovation despite challenges in Washington.